MLchartDataset catalogue

Zarxio

Term · Oncology and biomedicine · MLC-T-ONC-009461

A drug that contains the active ingredient filgrastim and is used to treat neutropenia (a lower-than-normal number of white blood cells), prevent infection, and prepare the blood for the collection of certain types of blood cells. Zarxio is used in patients who have certain cancers and neutropenia caused by some types of chemotherapy and in patients who have severe chronic neutropenia that is not caused by cancer treatment. It is also used before an autologous stem cell transplant. Zarxio helps the bone marrow make more white blood cells. It is a type of colony-stimulating factor.

Table 1. Record
IdentifierMLC-T-ONC-009461
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009461",
  "term": "Zarxio",
  "field": "Oncology and biomedicine",
  "definition": "A drug that contains the active ingredient filgrastim and is used to treat neutropenia (a lower-than-normal number of white blood cells), prevent infection, and prepare the blood for the collection of certain types of blood cells. Zarxio is used in patients who have certain cancers and neutropenia caused by some types of chemotherapy and in patients who have severe chronic neutropenia that is not caused by cancer treatment. It is also used before an autologous stem cell transplant. Zarxio helps the bone marrow make more white blood cells. It is a type of colony-stimulating factor.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/zarxio/"
}

Record 17,606 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.